Ak. Sinha et al., Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo, LIFE SCI, 65(25), 1999, pp. 2687-2696
Administration of physiologic amounts of insulin in mice (200 mu units/g bo
dy weight) resulted in 9 fold increase of basal nitric oxide level from 0.5
1+/-0.1224 nmol/ml (mean+/-SD, n=12) to 4.45+/-0.645 nmol/ml after 30min of
the injection of the hormone. Since NO is a potent inhibitor of platelet a
ggregation both in vitro and in vivo, we tested the possibility whether the
administration of the hormone would result in the in vivo inhibition of th
rombosis through the increase of NO level in the circulation. It was found
that administration of insulin (200 mu units/g body weight) in mice protect
ed >90%(p<0.00001, n=500) of these animals from death due to thrombosis in
the coronary arteries induced by ADP injection in the heart. This effect of
insulin in vivo was found to be directly related to the hormone induced in
crease of NO level in the system. The thromboprotective effect of insulin c
ould not be achieved by using either prostacyclin, a well known antithrombo
tic agent or its stable probe prostaglandin E-1 instead of insulin. The eff
icacy of insulin was neither related to the blood glucose level nor was the
consequence of the hypoglycemic effect of the hormone. In contrast, inhibi
tion of insulin induced increase of NO level resulted in the complete loss
of the thromboprotective effect of the hormone. These results suggest that
insulin besides being a hypoglycemic hormone could also be a potent antithr
ombotic humoral factor.